Search research articles
Contact Us
Filters
Showing results (61-70 of 131) with videos related to
Page
of 14
Sort By:
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
Stefano Cavalieri, Daria Maria Filippini, Arianna Ottini, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
November 10, 2023
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Oral Oncology
|
February 5, 2022
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials
Deborah Lenoci, Andrea Carenzo, Stefano Cavalieri, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
December 17, 2024
Corrigendum to "Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities" [Transl. Res. 265 (2024) 1-16]
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Oncology
|
May 22, 2019
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents
Stefano Cavalieri, Federica Perrone, Massimo Milione, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 5, 2018
Lenvatinib-induced renal failure: two first-time case reports and review of literature
Stefano Cavalieri, Laura Cosmai, Augusto Genderini, et al.
Expert Opinion on Investigational Drugs
|
March 23, 2019
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2019
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
Roberta Depenni, Maria Cossu Rocca, Daris Ferrari, et al.
Frontiers in Oncology
|
February 3, 2023
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
Stefano Cavalieri, Imperia Nuzzolese, Arianna Ottini, et al.
Frontiers in Genetics
|
March 30, 2026
Fragmenting the future with FLARE: a comprehensive fragmentomics pipeline based on long-read nanopore sequencing
Marica Ficorilli, Marta Lucchetta, Deborah Lenoci, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 131) with videos related to
Sort By:
Page
of 14
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
Stefano Cavalieri, Daria Maria Filippini, Arianna Ottini, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
November 10, 2023
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Oral Oncology
|
February 5, 2022
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials
Deborah Lenoci, Andrea Carenzo, Stefano Cavalieri, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
December 17, 2024
Corrigendum to "Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities" [Transl. Res. 265 (2024) 1-16]
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Oncology
|
May 22, 2019
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents
Stefano Cavalieri, Federica Perrone, Massimo Milione, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 5, 2018
Lenvatinib-induced renal failure: two first-time case reports and review of literature
Stefano Cavalieri, Laura Cosmai, Augusto Genderini, et al.
Expert Opinion on Investigational Drugs
|
March 23, 2019
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2019
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
Roberta Depenni, Maria Cossu Rocca, Daris Ferrari, et al.
Frontiers in Oncology
|
February 3, 2023
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
Stefano Cavalieri, Imperia Nuzzolese, Arianna Ottini, et al.
Frontiers in Genetics
|
March 30, 2026
Fragmenting the future with FLARE: a comprehensive fragmentomics pipeline based on long-read nanopore sequencing
Marica Ficorilli, Marta Lucchetta, Deborah Lenoci, et al.
Page
of 14